Skoči na glavni sadržaj

Stručni rad

https://doi.org/10.15836/ccar.2015.157

The Role of Sartans in Cardiovascular Prevention

Ljiljana Banfić ; Medicinski fakultet Sveučilišta u Zagrebu, Klinički bolnički centar Zagreb, Zagreb, Hrvatska


Puni tekst: hrvatski pdf 333 Kb

str. 157-161

preuzimanja: 454

citiraj

Puni tekst: engleski pdf 333 Kb

str. 157-161

preuzimanja: 570

citiraj


Sažetak

The application of angiotensin receptor blockers (AT1) in cardiovascular prevention is based on the treatment of arterial hypertension. Telmisartan, a medication from the sartan group, has not only an antihypertensive effect but proven pleiotropic, metabolic, biohumoral, antiproliferative, and vascular effects – the basic processes of vascular aging as well as the progression of atherosclerosis, a disease with a high mortality that requires early risk recognition and comprehensive primary and secondary cardiovascular prevention. Based on scientific evidence, telmisartan has been proven to provide a well tolerated antihypertensive effect over 24 hours, and is indicated in the prevention of cardiovascular diseases.

Ključne riječi

angiotensin receptor blockers; cardiovascular prevention; telmisartan

Hrčak ID:

141138

URI

https://hrcak.srce.hr/141138

Datum izdavanja:

5.7.2015.

Podaci na drugim jezicima: hrvatski

Posjeta: 2.071 *